SATURDAY, SEPTEMBER 24, 2016

Physician who had Ebola released after Aethlon Hemopurifier treatment

The Aethlon Hemopurifier is a first-in-class bio-filtration device that removes viruses and immunosuppressive proteins from the bloodstream of Ebola-infected individuals. | Photo courtesy of Aethlon Medical

An Ebola patient reportedly has been discharged from Frankfurt University Hospital in Germany.

The patient was a Ugandan physician who became infected with the disease in Sierra Leone, where he was treating other Ebola patients. He was treated with Aethlon Hemopurifier therapy.

Aethlon Medical is a company that creates therapeutic devices to address such maladies as infectious disease, cancer and neurodegenerative disorders.

The Aethlon Hemopurifier is a bio-filtration device that works at eliminating viruses and immunosuppressive proteins from the circulatory system of Ebola patients. When the Ugandan physician started treatment, he was unconscious and experiencing organ failure. After a single 6.5-hour Hemopurifier treatment, the virus started to dissipate, and eventually, the virus was undetectable after five days.

Hemopurifier therapy is available to treat Ebola patients in the U.S.  through the FDA's expanded-access "emergency use" protocols when an alternative therapy is unavailable.

Currently, no antiviral therapy or vaccine has proven to be effective against the Ebola virus in humans, but that may soon change as Aethlon will soon begin the first U.S. Hemopurifier clinical trials once the FDA approves an Investigational Device Exemption (IDE).

Organizations in this story

Aeras 1405 Research Blvd Rockville, MD 20850

Get notified the next time we write about Aeras!